Biology & Therapeutics
Scientific diligence, translational strategy, therapeutic positioning, clinical development logic, and interpretation of complex biology.
Helen works selectively with founders, investors, and organizations that need to understand not only whether a biological idea is compelling, but how it can become a credible product, company, or development program.
Scientific diligence, translational strategy, therapeutic positioning, clinical development logic, and interpretation of complex biology.
Founder advisory, innovation–market fit, portfolio expansion, scientific storytelling, partnerships, global sourcing, and the strategic decisions that shape a growing company.
Helen works with founders, investors, universities, accelerators, and institutions through selected advisory engagements, workshops, speaking programs, and interdisciplinary experiences.
Scientific and strategic guidance for companies and investors navigating product development, innovation–market fit, portfolio expansion, partnerships, and global growth.
Focused programs for accelerators, universities, research institutes, and leadership teams, designed around the organization's questions and stage of development.
Keynotes, seminars, panels, salons, and private events bringing together science, entrepreneurship, culture, and the art of living well.
Helen speaks across biotechnology, entrepreneurship, innovation, leadership, and the ways science reshapes how we understand culture, behavior, and living well.
Each engagement reflects a different way Helen brings scientific depth, strategic thinking, and cultural perspective into the room.
Selected as one of three StartX Med founders to present to Chanel's leadership on longevity, mitochondria, and what luxury and fashion can learn from biotechnology's approach to hidden drivers of behavior.
Available as a tailored executive briefing or innovation workshop for corporate leadership teams.
An interdisciplinary salon exploring how scent shapes memory, mood, identity, and presence—and how illness, treatment, hormones, aging, and metabolic change can alter perception, preference, and the way we experience ourselves.
Designed for professional communities, leadership groups, and private cultural programs.
Set along the Sonoma Coast, these intimate gatherings bring together food, live music, thoughtful hospitality, and practical ideas for living well. Co-hosted with Dr. Thomas Tomich, Distinguished Professor Emeritus of Sustainable Agriculture at UC Davis.
Available as a curated private gathering for leadership teams, founders, and invited communities.
A recurring five-day program helping scientists and technical founders translate emerging technologies into credible ventures, market strategies, and global opportunities.
Also available as focused half-day workshops on Silicon Valley founder mindset, pitch critique, and story and message crafting.
Helen Chen, Ph.D., is a biotech founder, scientist, and advisor with more than fifteen years of experience across drug discovery, translational strategy, entrepreneurship, and company leadership.
She is the Co-Founder and CEO of Alixia, a biotechnology company developing first-in-class therapeutics for cancer and age-related disease. Her broader work spans scientific advisory, founder mentoring, international education, and interdisciplinary programs connecting biology with culture and human experience.
An award-winning scientist and pianist, Helen received her B.S. in Molecular Biochemistry & Biophysics from Yale University and her Ph.D. in Biomedical Sciences from the University of California, San Diego.
LinkedInHelen welcomes selected advisory projects, speaking invitations, scientific collaborations, interdisciplinary programs, and experiences.